Prospective follow-up shows medium-term CT findings in COVID-19 survivors, indicating older age and comorbidities are linked to residual abnormalities.
Key Points
To analyze pulmonary findings in COVID-19 survivors three months after recovery.
Prospective follow-up study with 80 participants
History of COVID-19 pneumonia verified by RT-PCR testing
Chest CT scans evaluated at three months post-recovery
65% of patients showed complete radiological resolution
35% had residual pulmonary CT findings, mainly ground-glass opacity and fibrous stripes
Older patients and those with comorbidities were more likely to have residual abnormalities